HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages.

Abstract

OBJECTIVE:

Although it is accepted that macrophage glycolysis is upregulated under hypoxic conditions, it is not known whether this is linked to a similar increase in macrophage proinflammatory activation and whether specific energy demands regulate cell viability in the atheromatous plaque.

APPROACH AND RESULTS:

We studied the interplay between macrophage energy metabolism, polarization, and viability in the context of atherosclerosis. Cultured human and murine macrophages and an in vivo murine model of atherosclerosis were used to evaluate the mechanisms underlying metabolic and inflammatory activity of macrophages in the different atherosclerotic conditions analyzed. We observed that macrophage energetics and inflammatory activation are closely and linearly related, resulting in dynamic calibration of glycolysis to keep pace with inflammatory activity. In addition, we show that macrophage glycolysis and proinflammatory activation mainly depend on hypoxia-inducible factor and on its impact on glucose uptake, and on the expression of hexokinase II and ubiquitous 6-phosphofructo-2-kinase. As a consequence, hypoxia potentiates inflammation and glycolysis mainly via these pathways. Moreover, when macrophages' ability to increase glycolysis through 6-phosphofructo-2-kinase is experimentally attenuated, cell viability is reduced if subjected to proinflammatory or hypoxic conditions, but unaffected under control conditions. In addition to this, granulocyte-macrophage colony-stimulating factor enhances anerobic glycolysis while exerting a mild proinflammatory activation.

CONCLUSIONS:

These findings, in human and murine cells and in an animal model, show that hypoxia potentiates macrophage glycolytic flux in concert with a proportional upregulation of proinflammatory activity, in a manner that is dependent on both hypoxia-inducible factor -1α and 6-phosphofructo-2-kinase.

• Authors: Ahmed Tawakol, Parmanand Singh, Marina Mojena, María Pimentel-Santillana, Hamed Emami, Megan MacNabb, James H F Rudd, Jagat Narula, José A Enriquez, Paqui G Través, María Fernández-Velasco, Ramón Bartrons, Paloma Martín-Sanz, Zahi A Fayad, Alberto Tejedor, Lisardo Boscá
• Journal: Arteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 35 Issue 6 Pg. 1463-71 (Jun 2015) ISSN: 1524-4636 [Electronic] United States
• PMID: 25882065 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © 2015 American Heart Association, Inc.

Chemical References

• Hypoxia-Inducible Factor 1, alpha Subunit
• Tumor Necrosis Factor-alpha
• Phosphofructokinase-2

Topics

• Animals
• Atherosclerosis (metabolism)
• Cell Hypoxia
• Disease Models, Animal
• Glycolysis
• Humans
• Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
• Inflammation (metabolism)
• Macrophages (metabolism)
• Mice
• Phosphofructokinase-2 (metabolism)
• Tumor Necrosis Factor-alpha (metabolism)